DALIAN, China -- Chinese drugmaker Sinopharm is preparing phase three clinical trials for a coronavirus vaccine candidate in the United Arab Emirates.
Sinopharm affiliate China National Biotec Group received approval from UAE health authorities to run the late-stage trials, the company said late Tuesday. The Middle Eastern country plans to host the vaccine's production if the study is completed successfully.
